Susan Hasty, Publisher
Table of Contents . . . March 18th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly and Law | Other Publications
Adventrx Pharmaceuticals, Inc. - Cancer center receives grant for HIV/AIDS vaccine therapy
Medical Research Council Laboratories, Banjul - Cellular immunity similar for asymptomatic HIV-1 and -2-infected patients
United Nations - AIDS threat growing throughout Europe
World AIDS Foundation - Civil strife in Haiti could derail progress on HIV transmission rates
Abbott Diagnostika GmbH & Co. KG - New automated ELISA reduces detection time of HIV-specific antibodies
Bayer Pharmaceutical Corp. - Tat-binding surface of CBP KIX domain identified
Bionor A/S - Magnetic particle-based HIV confirmatory immunoassay suitable for use
CHU, Vaudois - Functionally distinct HIV-specific CD4 cells needed for viral control
Dana-Farber Cancer Institute - Protein prevents HIV RNA virus from converting to DNA in Old World monkeys
Fred Hutchinson Cancer Research Center - T-cell Fas expression may predict virological outcome
Harvard University - M. tuberculosis recall antigens inhibit HIV replication
HIV/AIDS - Scared by SARS, fewer Hong Kong people test for HIV
HIV/AIDS - South Dakota woman pleads not guilty to HIV charge
HIV/AIDS - U.N. AIDS: HIV rising again in West, rampaging in East Europe and Central Asia
HIV/AIDS Funding - Bush unveils emergency plan in fight against AIDS
HIV/AIDS Prevention - Scientists say monkeys may hold key to preventing HIV infection
HIV/AIDS Treatment - "Universal access" to HIV/AIDS treatment pledged by Europe, Central Asia
Indiana University - HIV Tat induces XCL1 expression by lymphocytes
Karolinska Hospital - Social networks of African HIV patients in Sweden characterized
Massachusetts General Hospital - In vivo HIV protease imaging in gliomas achieved
New Mexico State University - Microtiter plate device enables fast, high-volume HIV IN purification
NIPER, Punjab - Novel system enhances transdermal AZT delivery
Pasteur Institute, Lille - Genes involved in murabutide-induced HIV suppression identified
Poliomyelitis - Emergency polio immunization campaign hampered by vaccine boycott
Roche - Studies: Potential for Invirase plus ritonavir and protease inhibitors
Targeted Genetics Corp. - Germany begins its first AIDS vaccine trial, partnering with IAVI
U.S. National Cancer Institute - Nonrandom double HIV infection identified
U.S. National Institutes of Health - X4 HIV suppresses R5 strains in lymphoid tissue
Univ. of California, San Diego - Hydrogen bonding role in HIV protease-catalyzed enzymatic reaction clarified
Univ. of California, San Francisco - Effects of p53 on KSHV cyclin-induced lymphomagenesis clarified
Univ. of California, San Francisco - Polycationic nanoparticle formulation enhances HIV env DNA vaccine
Univ. of Texas SW Medical Center - High IL-7 levels alone do not preserve T-cell counts in SIV
University of California,San Francisco - Calcium-dependent mechanism identified for HIV-induced neuropathy
University of Oxford - Process of HIV cell-to-cell transfer characterized
University of Rome 'La Sapienza' - Whole virus needed for accurate viral growth assay results
Walter Reed Army Medical Center - Study shows no vaccinia viremia after smallpox vaccination
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.